Cite
APA Citation
Grohe, C., Gleiber, W., Krüger, S., Mueller-Huesmann, H., Schulze, M., Atz, J., & Kaiser, R. (n.d.). 66P Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098453721.0x000029